• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchGRI Bio
    Picture of GRI Bio logo

    GRI — GRI Bio News Story

    $1.400.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    • Market Cap
      $3.06m
    • Enterprise Value
      -$7.89m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • GRI Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    GRI Dividends
    All News

    NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:18 PM

    Picture of GRI Bio logoGRI Bio
    04/11/2021 17:19
    NASDAQ TRADE HALT  VLON.O  VOLATILITY TRADING PAUSE AT 01:18 PM
    

    Recent news on GRI Bio

    See all news
    • GRI Bio Inc reports results for the quarter ended June 30 - Earnings Summary

      14/08/2026 15:08
    • GRI Bio Inc expected to post a loss of $1.19 a share - Earnings Preview

      10/08/2026 15:14
    • Brief: Gri Bio Secures FDA Orphan Drug Designation For Gri-0621 (Tazarotene) In Idiopathic Pulmonary Fibrosis

      18/06/2026 14:12
    • GRI Bio Q1 net loss narrows on lower R&D expenses

      14/05/2026 13:42
    • GRI Bio raises $14.5 mln to fund operations into Q1 2027

      04/02/2026 13:56

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.